An observational study in Chronic Obstructive Pulmonary Disease, sponsored by China-Japan Friendship Hospital. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-04.
Sponsored by China-Japan Friendship Hospital · Observational
The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.
3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.
This study's planned enrollment of 7,600 is above the median of 157 across 929 observational studies indexed under Lung Diseases.
Browse Lung Diseases studies →China-Japan Friendship Hospital is the lead sponsor of 173 studies on the registry; 109 are open to participants now.
Counted across the registry records on this site, refreshed daily.
AECOPD-IRS plans to enroll 7600 hospitalized patients (≥ 18 years old with main diagnosis as AECOPD). Sample size estimation is based on estimated mortality of AECOPD hospitalized patients (\~5%). Study patients will be recruited from 40-60 hospitals across China,each hospital will recruit 152-190 patients. Hospital selection follows a multi-stage sampling strategy.
≥18 years of age; hospitalized patients with main diagnosis as AECOPD.
Exclusion Criteria:
Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.
In-hospital mortality
All-cause and cause-specific mortality will be described.
Time frame: 12 months
Readmission
Readmission rate caused by AECOPD within 1 month after discharged from hospital.
Time frame: 12 months
All-cause and cause-specific mortality
All-cause and cause-specific mortality will be described at different time points (1, 2, 3 years)
Time frame: 3 years
Recurrence of acute exacerbation of COPD
Frequency of AECOPD recurrence will be described during follow-ups, the date of first recurrence after discharge will be analysed.
Time frame: 3 years
Lung function and quality of life assessment
Lung function will be measured regularly, quality of life will be assessed by questionnaires
Time frame: 3 years
Healthcare costs
Direct costs of hospital stay will be recorded.
Time frame: 12 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
China-Japan Friendship Hospital